You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

medullary thyroid carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin

Completed
  • Medullary Thyroid Carcinoma
  • Nodular Goiter
  • Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
  • Pilar, Buenos Aires, Argentina
    Hospital Universitario Austral
Oct 5, 2023

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

Not yet recruiting
  • Non-Medullary Thyroid Carcinoma
  • Digoxin tablet
  • (no location specified)
Aug 20, 2022

Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)

Enrolling by invitation
  • Diabetes
  • +3 more
  • No treatment given
  • Morgantown, West Virginia
    United BioSource, LLC
Oct 4, 2022

Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

Not yet recruiting
  • Medullary Thyroid Cancer
  • +3 more
  • Groningen, Netherlands
    University Medical Centre Groningen
Sep 8, 2022

Medullary Thyroid Carcinoma Trial in Angers, Nantes, Saint-Herblain (• TF2 and 68 Ga-IMP-288)

Completed
  • Medullary Thyroid Carcinoma
  • • TF2 and 68 Ga-IMP-288
  • Angers, France
  • +2 more
Jul 22, 2022

Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

Recruiting
  • Thyroid Cancer, Nonmedullary
  • Colon Carcinoma
  • no intervention will take place
  • Nijmegen, Gelderland, Netherlands
    RadboudUMC
Sep 21, 2022

Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

Recruiting
  • Medullary Thyroid Cancer
  • Anlotinib Hydrochloride Capsule
  • Hefei, Anhui, China
  • +18 more
Apr 14, 2023

Children and Adults With Medullary Thyroid Cancer

Recruiting
  • Medullary Thyroid Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    A Detailed Look At What Patients Experience In Medullary Thyroid

    Not yet recruiting
    • Medullary Thyroid Cancer
      • San Francisco, California
        Power Life Sciences
      Oct 6, 2023

      Surgical Management of Advanced Thyroid Cancer

      Recruiting
      • Thyroid Carcinoma
      • +6 more
      • Thyroidectomy with or without lymphadenectomy or multivisceral resection
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Mar 31, 2023

      Medullary Thyroid Carcinoma Trial in China (HA121-28 tablets)

      Recruiting
      • Medullary Thyroid Carcinoma
      • HA121-28 tablets
      • Beijing, Beijing, China
      • +12 more
      Feb 7, 2022

      Myeloid Cell Reprogramming in Thyroid Carcinoma

      Completed
      • Thyroid Cancer
        • Nijmegen, Netherlands
          Radboudumc
        Jan 25, 2022

        Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

        Not yet recruiting
        • Medullary Thyroid Cancer
        • Cordoba, Spain
        • +1 more
        Jan 11, 2023

        RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

        Not yet recruiting
        • RET-altered Non Small Cell Lung Cancer
        • +3 more
        • Chang chun, Jilin, China
          Jinlin Province Cancer Hosipital
        Dec 21, 2022

        Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

        Recruiting
        • Malignant Thyroid Gland Neoplasm
        • +6 more
        • Quality-of-Life Assessment
        • +3 more
        • Ann Arbor, Michigan
        • +1 more
        Jan 24, 2023

        Radioactive Iodine on the Immune System in Thyroid Cancer

        Not yet recruiting
        • Thyroid Carcinoma, Nonmedullary
        • Blood drawing
        • Nijmegen, Netherlands
          Radboud University Medical Center
        Aug 13, 2023

        Metastatic Medullary Thyroid Cancer Trial in Philadelphia (single dose of CART-GFRa4 cells, Fludarabine, Cyclophosphamide)

        Recruiting
        • Metastatic Medullary Thyroid Cancer
        • single dose of CART-GFRa4 cells
        • +2 more
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Sep 16, 2022

        Thyroid Carcinoma

        Recruiting
        • Differentiated Thyroid Carcinoma
        • Medullary Thyroid Carcinoma
        • Immunohistochemistry (IHC)
        • +2 more
        • L'Hospitalet De Llobregat, Barcelona, Spain
        • +11 more
        Mar 22, 2022

        Kidney Medullary Carcinoma, Loss of INI 1 Protein Expression, Stage III Renal Cell Cancer AJCC v8 Trial in Houston (Ipilimumab,

        Active, not recruiting
        • Kidney Medullary Carcinoma
        • +3 more
        • Ipilimumab
        • Nivolumab
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 22, 2022

        Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

        Not yet recruiting
        • Adrenal Cortical Carcinoma
        • +3 more
        • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
        • Shanghai, Shanghai, China
          Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
        Nov 19, 2023

        Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma Trial in United States (Best Practice, Blood

        Recruiting
        • Cardiovascular Disorder
        • +8 more
        • Best Practice
        • +4 more
        • Creve Coeur, Missouri
        • +24 more
        Aug 10, 2022

        Medullary Thyroid Cancer Trial (Ponatinib)

        Withdrawn
        • Medullary Thyroid Cancer
        • (no location specified)
        Oct 6, 2021

        Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

        Active, not recruiting
        Has Results
        • Solid Tumor
        • Medullary Thyroid Cancer
        • Guangzhou, Guangdong, China
        • +12 more
        May 9, 2022

        Metastatic Sporadic Medullary Thyroid Cancer Patients and

        Completed
        • Metastatic Sporadic Medullary Thyroid Cancer
          • Milano, Italy
            Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
          Sep 29, 2021